Please login to bookmark Close
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex’ consultant took the brunt of it.
ACCC’s case bad for business, Aboriginal art supplier tells court
Please login to bookmark Close
An Aboriginal art and souvenir supplier says its business has taken a hit since the ACCC accused it of selling fakes, and the company wants to expedite the regulator’s case to avoid further damage, a court heard Wednesday.
ASIC confirms AMP probe, as Morrison warns of jail time
Please login to bookmark Close
The corporate regulator has confirmed it is investigating AMP over its ‘fees for no service’ practice revealed at the Hayne Royal Commission in stunning testimony Treasurer Scott Morrison on Wednesday called “deeply disturbing”.
Former NAB adviser banned for stealing $2 million from clients
Please login to bookmark Close
A former NAB financial adviser has been permanently banned from providing financial services after an ASIC investigation found he fleeced clients out of at least $2 million.
Settlement release frees Fairfax from 2nd defamation case
Please login to bookmark Close
A judge has dismissed a second defamation case against Fairfax Media brought by an associate of a murdered Sydney businessman, ruling the plaintiff waived his right to sue again after dropping an earlier suit against the publisher for a $75,000 payout.
RMIT whistleblower wins subpoena request
Please login to bookmark Close
A former RMIT worker suing the university for allegedly firing him after he blew the whistle on a colleague for selling exam answers to students has won a bid to subpoena documents from the Victorian Ombudsman.
Geneva Labs can’t expand fake Bio-Oil case
Please login to bookmark Close
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.
Writers’ Guild slams “mishmash” of evidence in royalties case
Please login to bookmark Close
A barrister for the Australian Writers’ Guild has blasted documents produced by the non-profit Screenrights in a court battle over tens of millions of dollars in royalties payments, calling the evidence a “complete mishmash”.
S&P analysts take stand in class action trial
Please login to bookmark Close
Two high ranking analysts from S&P Global have distanced themselves from the decision making process at the heart of a class action over toxic financial products given healthy ratings by the agency ahead of the global financial crisis.
Independence of Clayton Utz report questioned at Royal Commission
Please login to bookmark Close
The independence of a report by law firm Clayton Utz to ASIC over AMP’s practice of charging customers for services not performed was called into question Tuesday at the Hayne Royal Commission.